EL7.AI
StocksMediumUpdated•Originally published 16 July 2026•Updated 16 July 2026•
1 min read

TSMC Shares Tumble 6% Despite Beating Sales and Earnings Estimates

Key Facts

1TSMC reported record profits driven by AI demand, but shares slipped as investors engaged in profit-taking.
2TSMC announced an additional $100 billion investment in the United States to bolster manufacturing capabilities.
3UnitedHealth shares rallied following earnings that indicated the company is recovering from previous investor concerns.

In a stark contrast between operational strength and market reaction, TSMC reported financial results that exceeded both sales and earnings per share (EPS) expectations. Despite beating these core estimates, the stock faced intense selling pressure, triggering a 6% drop in pre-market trading as the price tumbled from $422 to $397 according to recent reports.

This sharp decline reflects investor anxiety over growth sustainability in the semiconductor space, even as the company maintains its massive $100 billion investment plan in the U.S. Compared to industry peers, TSM is exhibiting higher volatility than Samsung and SK Hynix, while healthcare giant UnitedHealth showed relative stability, closing at $418.52 (per market data on July 15, 2026).

Traders should closely monitor the new support level at $397 (pre-market close on July 16, 2026), as this level serves as a critical test for risk appetite. In the absence of immediate corporate catalysts, market attention shifts to the Fed's Monetary Policy Report scheduled for July 10 (per the economic calendar), which will likely influence liquidity flows into high-growth tech sectors.